Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited, has received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Hubli Circle, Karnataka. The suspension is for three days for a store located at Ganeshpeth Hubli, Karnataka. The order was received on April 30, 2026. The suspension was issued under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company has disclosed a potential revenue loss of Rs 0.97 lakhs due to this suspension.
This is a minor regulatory action affecting only one store for three days with a negligible revenue impact of less than Rs 1 lakh. Given the size of Medplus operations, this suspension is unlikely to have any material impact on the company's stock price or financials.